Biofabricated the patient-specific tumor-on-a-chip system for medical prediction
The key technology of Patient Derived Tumor Spheroids (PDTS) is to create an in-vitro patient tumor microenvironment and tumor-like properties, furthermore, predict various cancer antidrug effectiveness to each patient via the high-throughput and high-quality cell viability detection and biomarker analysis. Therefore, this project established several technologies including extracellular matrix fabrication, bioink design, cell population identification, and tumor physiological environment for the upon goal.
2022-11-21